Q&A Session #4

Iltefat H. Hamzavi, MD, FAAD – Invited Speaker

Phototherapy for Vitiligo: How to Optimize and What the Future Holds

Simone Nichole Boeckmann Montgomery, BA

Vitiligo and Psychological Comorbidities: A Retrospective Analysis in an Urban Population

Youwen Zhou, MD, PhD

Therapeutic Response Biomarkers for Vitiligo Patients on Narrow Band UVB and Topical Tacrolimus Combination Therapy

Haitham M. Saleh, Msc

A Comparative Pilot Study of Dipstick versus Open-Spray Cryotherapy Techniques as Depigmentation Treatments for Vitiligo

Davinder Parsad, MD

Recent Advances in the Surgical Management of Vitiligo

Q&A Session #3

Jung Min Bae, MD, PhD Oral Abstract

An Identification of Potential Therapeutics for Vitiligo by Mass Screening for 1,732 Medicines in Korean National Health Insurance Database

John E. Harris, MD, PhD – Oral Abstract

Survey Investigating the Prevalence of Vitiligo and Vitiligo Signs among Adults in Europe, Japan, and the United States

Saad Altalhab, MBBS

Risk Factors of Infection Post Non-cultured Melanocyte Keratinocyte Transplantation for Vitiligo